XPO241220C180000
- 0.40
- 0.000.00%
XPO Newsroom
Barclays Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $170
J.P. Morgan Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $160
XPO Is Maintained at Overweight by JP Morgan
BMO Capital Maintains XPO(XPO.US) With Buy Rating
Citi Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $179
BofA Securities Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $171
XPO Analyst Ratings
Stephens & Co. Reiterates Overweight on XPO, Maintains $165 Price Target
Barclays Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $170
Barclays Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $170
XPO Analyst Ratings
Citi Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $179
TD Cowen Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $150
Stifel Maintains XPO(XPO.US) With Buy Rating, Raises Target Price to $131
TD Cowen Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $150
Wells Fargo Maintains XPO(XPO.US) With Buy Rating, Maintains Target Price $150
A Quick Look at Today's Ratings for XPO(XPO.US), With a Forecast Between $85 to $159
XPO Price Target Raised to $150.00/Share From $119.00 by Wells Fargo
XPO Is Maintained at Overweight by Barclays
XPO Is Maintained at Buy by TD Cowen